Programme Director - Theatre Expansion and Modernisation

The Programme Director will provide overall leadership to the Trust Major Programme which includes but is not limited to, the build of the new Guys Surgical Hub, the rolling refurbishment of all existing theatres, the ventilation strategy, other theatre expansion proposals, Endourology, the Hybrid Theatres and capacity / demand management for the future. The role will also take a lead role in the Robotic Surgery strategy, planning and implementation., GSTT has a large estate of >50 existing theatres across the Trust's five hospital sites . The theatres are in varying stages of repair and upkeep with some more modern theatres and some ageing estate. Modelling suggests that due to rising demand, GSTT urgently needs to add additional theatre capacity as well as maintaining and updating the existing theatre estate. The Trust is committing £100m of capital to build a new state of the art theatre block (the 'Guys Surgical Hub') on the Guys site which will add significant new Theatre Capacity for South East London.,

• Haematology, Cellular Pathology and supporting services
• Gastrointestinal Medicine and Surgery
• Surgery (Orthopaedics and Plastics)
• Theatres, Anaesthesia and Perioperative
• Transplant, Renal and Urology
We are focused on delivery of services to the local population of South East London but also provide a large number of specialist services across the South East of England. We currently have the largest robotic surgery programme in the UK and are committed to developing our robotic centre of excellence. We oversee the largest theatre complex in the NHS and have an ambitious theatre development programme underway. Our endoscopy service is JAG accredited and highly commended by the team. The Cancer and Surgery Clinical Group leads the delivery of the surgical and cancer strategies Trust wide working across the organisation in conjunction with the other three Clinical Groups to support the delivery of our ambitions. We are heavily focused on elective recovery with a strong focus on increasing our throughput and productivity through both improvement initiatives and new innovations such as the development of our High-Volume Low Complexity (HLVC) site for South East London at Sidcup and establishing the "high intensity theatre (HIT) list" concept which has been showcased across the NHS and national media.

The Cancer and Surgery Clinical Group was formed in 2021 and consists of seven Directorates with a budget of c.£500 million:
• Oncology